Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Helicobacter Pylori Eradication According to Sequencing-based 23S Ribosomal RNA Point Mutation Associated With Clarithromycin Resistance

NCT03884348 is registered in ClinicalTrials.gov with Kangdong Sacred Heart Hospital as lead sponsor.

NCT NCT03884348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Helicobacter Pylori Eradication According to Sequencing-based 23S Ribosomal RNA Point Mutation Associated With Clarithromycin Resistance
Lead sponsor
Kangdong Sacred Heart Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
December 31, 2018
Enrollment
431 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant strain, helicobacter pylori infection